BSX · NYSE · CIK 0000885725
BOSTON SCIENTIFIC CORP
BOSTON SCIENTIFIC CORP’s most recent SEC filing in our snapshot is a Form 8-K filed on Oct 7, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $20.1B and net income of $2.9B, according to its XBRL data on EDGAR. Its EDGAR record lists 56 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- BOSTON SCIENTIFIC CORP
- Ticker
- BSX
- SEC Central Index Key (CIK)
- 0000885725
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus (code 3841)
- Business address
- MARLBOROUGH, MA
- State or country of incorporation
- DE
- Fiscal year ends
- December 31
- SEC filer category
- Large accelerated filer
- Position in SEC ticker list
- #256 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from BOSTON SCIENTIFIC CORP’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2021 ended Dec 31, 2021 | FY2022 ended Dec 31, 2022 | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 | FY2025 ended Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $11.9B | $12.7B | $14.2B | $16.7B | $20.1B |
| Net income | $1.0B | $698.0M | $1.6B | $1.8B | $2.9B |
| Diluted EPS | $0.69 | $0.45 | $1.07 | $1.25 | $1.94 |
| Total assets | $32.2B | $32.5B | $35.1B | $39.4B | $43.7B |
| Cash and equivalents | $1.9B | $928.0M | $865.0M | $414.0M | $2.0B |
XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = ProfitLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
| Filed | Form | What it is | Original |
|---|---|---|---|
| Feb 17, 2026 | 10-K | Annual report· period Dec 31, 2025 | Document · Index |
| Aug 3, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Oct 7, 2026 | 8-K | Director or officer change; Other events· period Oct 1, 2026 | Document · Index |
| Mar 18, 2026 | DEF 14A | Definitive proxy statement· period Mar 18, 2026 | Document · Index |
Recent SEC filings
The 40 newest documents filed by or about BOSTON SCIENTIFIC CORP, by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Oct 7, 2026 | 8-K | Director or officer change; Other events· period Oct 1, 2026 | Document · Index |
| Sep 23, 2026 | 8-K | Director or officer change· period Sep 21, 2026 | Document · Index |
| Sep 8, 2026 | 8-K | Cybersecurity incident· period Sep 7, 2026 | Document · Index |
| Sep 3, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 2, 2026 | Document · Index |
| Aug 26, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 25, 2026 | Document · Index |
| Aug 26, 2026 | 8-K | Other events· period Aug 26, 2026 | Document · Index |
| Aug 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 11, 2026 | Document · Index |
| Aug 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 10, 2026 | Document · Index |
| Aug 7, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 5, 2026 | Document · Index |
| Aug 6, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Aug 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 3, 2026 | Document · Index |
| Aug 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 3, 2026 | Document · Index |
| Aug 3, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jul 31, 2026 | Document · Index |
| Aug 3, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jul 31, 2026 | Document · Index |
| Aug 3, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Jul 29, 2026 | 8-K | Results of operations· period Jul 29, 2026 | Document · Index |
| Jul 27, 2026 | 8-K | Exit or disposal costs· period Jul 21, 2026 | Document · Index |
| Jul 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jul 1, 2026 | Document · Index |
| Jun 24, 2026 | 11-K | Annual report of employee stock plans· period Dec 31, 2025 | Document · Index |
| Jun 1, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 28, 2026 | Document · Index |
| May 21, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 20, 2026 | Document · Index |
| May 21, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 20, 2026 | Document · Index |
| May 21, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 19, 2026 | Document · Index |
| May 21, 2026 | SD | Specialized disclosure report (conflict minerals) | Document · Index |
| May 18, 2026 | 8-K | Other events· period May 18, 2026 | Document · Index |
| May 18, 2026 | 8-K | Other events· period May 18, 2026 | Document · Index |
| May 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 8, 2026 | S-8 | Registration of employee benefit plan securities | Document · Index |
| May 6, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| May 5, 2026 | 8-K | Charter, bylaws or fiscal year change; Shareholder vote results· period Apr 30, 2026 | Document · Index |
| May 4, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 2, 2026 | Document · Index |
| May 4, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 2, 2026 | Document · Index |
Insider filing activity
56 Form 4 filings appear in BOSTON SCIENTIFIC CORP’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Surgical & Medical Instruments & Apparatus
- SYK STRYKER CORP
- MMM 3M CO
- BDX BECTON DICKINSON & CO
- MDLN Medline Inc.
- RMD RESMED INC
- DXCM DEXCOM INC
- WST WEST PHARMACEUTICAL SERVICES INC
- SOLV Solventum Corp
All 51 companies in Surgical & Medical Instruments & Apparatus· Companies headquartered in Massachusetts
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000885725 and XBRL company facts. BOSTON SCIENTIFIC CORP on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement